MOLCURE today announced the appointment of leading biotechnology executive-scientist Dr. Han Lim, M.B.B.S., Ph.D. as strategic advisor. Dr. Lim is currently the Chief Business Officer at DeepCure, Inc., and was formerly the Chief Business Officer at Atomwise Inc. He has also served on a number of boards and steering committees, and is a frequent speaker and panelist on artificial intelligence (AI) enabled drug discovery. Dr. Lim has broad operational and management experience in growing AI biotechnology companies. He is an internationally recognized leader in business development, having formed AI drug discovery partnerships with pharmaceutical and biotechnology companies, launched joint venture companies, and established collaborative research projects with more than 500 […]

MOLCUREは、本日バイオテクノロジーのトップエグゼクティブであるDr. Han Lim, M.B.B.S., Ph.D.,を戦略アドバイザーとして任命したことを発表しました。 詳細は以下のリンクをご覧ください。 Press release link:https://prtimes.jp/main/html/rd/p/000000006.000083912.html

The Committee on Bioeconomy’s visit to Tsuruoka Science Park on December 7th, was featured in the Keidanren Times.The Tsuruoka Science Park, where our Tsuruoka BioLab is located, is promoting advanced initiatives as the core of the Tsuruoka BioCommunity, which has been accredited by the government. Link (Japanese only): https://www.keidanren.or.jp/journal/times/2023/0101_09.html

バイオエコノミー委員会の鶴岡サイエンスパーク視察（12/7）の様子が、経団連タイムスに掲載されました。弊社、鶴岡バイオラボが入居している鶴岡サイエンスパークは、政府から認定を受けた鶴岡バイオコミュニティの中核として先進的な取り組みを進めています。 Link: https://www.keidanren.or.jp/journal/times/2023/0101_09.html

MOLCURE will be attending the #BIOTECHSHOWCASE in San Francisco.Our CEO, Ryu Ogawa will give a presentation on January 11th.Join us from Jan 9 to 11 to learn more about our AI-driven drug discovery platform.Contact us via partnering or email. Link: https://informaconnect.com/biotech-showcase/

MOLCUREは1月9日-11日にサンフランシスコで開催されるBIOTECH SHOWCASEに参加します。弊社CEOの小川が1月11日にBIOTECH SHOWCASE会場にてプレゼンテーションを行います。お問い合わせは、BIOTECH SHOWCASEのPartneringシステムまたは公式ページからご連絡ください。 Link: https://informaconnect.com/biotech-showcase/

Our CSO, Satoshi Tamaki, will speak at the 17th RIKEN Symposium on January 11th.He will introduce MOLCURE’s Antibody/Peptide Drug Discovery Platform using AI and Laboratory automation.The lecture will be in Japanese and begins at 15:55.We look forward to seeing you there. Link (Japanese only): http://www2.riken.jp/nano-med.eng.lab/bio-mono17.html

2023年1月11日開催の「第17回理化学研究所シンポジウム」にて、弊社CSOの玉木が講演を行います。場所は理化学研究所 和光地区 鈴木梅太郎記念ホールにて、参加費は無料です。玉木による講演は15:55より開始となります。ぜひご参加ください。 Link: http://www2.riken.jp/nano-med.eng.lab/bio-mono17.html

The administrative staff from the National Institutes of Technology in the Tohoku area visited MOLCURE as part of their joint training program. MOLCURE designs biopharmaceuticals with the combination of AI x Robots x Biology, and we are currently recruiting members.For more information, please visit the following link.Link: https://jobs.lever.co/molcure

東北地区国立高等専門学校事務職員のみなさまが、合同研修の一貫として、MOLCUREに視察にいらっしゃいました。 MOLCUREでは、AI x Robot x Bioを用いた医薬品デザインを行っており、メンバーを募集しています。ご興味のある方は、以下リンクを是非ご覧ください。Link: https://jobs.lever.co/molcure